A pending Trump administration proposal that would tie Medicare reimbursements to foreign countries’ drug prices could hurt a separate bipartisan effort in the Senate to lower drug prices because of an obscure budget rule.
The administration’s proposed rule, which has yet to be published, is expected to match payments for drugs administered in a doctor’s office more closely with what other countries pay.
Senators are weighing a separate measure on drug pricing by Iowa Republican
The administration proposal, ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.